Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection.
Saved in:
| Title: | Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection. |
|---|---|
| Authors: | Sudha P; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Pham P; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Niu W; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Liu E; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Wang L; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN., Truong G; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Ligocki C; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Al-Azzawi R; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Surapenini M; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Bray SM; Fountain Life Co, Indianapolis, IN., Vetrini F; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.; Undiagnosed Rare Disease Clinic, Indiana University School of Medicine, Indianapolis, IN., Czader M; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN., Tayeh MK; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Lee K; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Abonour R; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Suvannasankha A; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Walker BA; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.; Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN.; Myeloma Division, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL. |
| Source: | Blood advances [Blood Adv] 2026 Jan 13; Vol. 10 (1), pp. 95-105. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41092482 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sudha+P%22">Sudha P</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Pham+P%22">Pham P</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Niu+W%22">Niu W</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Liu+E%22">Liu E</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Truong+G%22">Truong G</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Ligocki+C%22">Ligocki C</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Al-Azzawi+R%22">Al-Azzawi R</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Surapenini+M%22">Surapenini M</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Bray+SM%22">Bray SM</searchLink>; Fountain Life Co, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Vetrini+F%22">Vetrini F</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.; Undiagnosed Rare Disease Clinic, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Czader+M%22">Czader M</searchLink>; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Tayeh+MK%22">Tayeh MK</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Lee+K%22">Lee K</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Abonour+R%22">Abonour R</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Suvannasankha+A%22">Suvannasankha A</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Walker+BA%22">Walker BA</searchLink>; Division of Hematolgy and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN.; Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN.; Myeloma Division, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jan 13; Vol. 10 (1), pp. 95-105. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41092482 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2025017721 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 95 Titles: – TitleFull: Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sudha P – PersonEntity: Name: NameFull: Pham P – PersonEntity: Name: NameFull: Niu W – PersonEntity: Name: NameFull: Liu E – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Truong G – PersonEntity: Name: NameFull: Ligocki C – PersonEntity: Name: NameFull: Al-Azzawi R – PersonEntity: Name: NameFull: Surapenini M – PersonEntity: Name: NameFull: Bray SM – PersonEntity: Name: NameFull: Vetrini F – PersonEntity: Name: NameFull: Czader M – PersonEntity: Name: NameFull: Tayeh MK – PersonEntity: Name: NameFull: Lee K – PersonEntity: Name: NameFull: Abonour R – PersonEntity: Name: NameFull: Suvannasankha A – PersonEntity: Name: NameFull: Walker BA IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 01 Text: 2026 Jan 13 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |